Covestor
MIRM icon

Covestor’s Mirum Pharmaceuticals MIRM Stock Holding History

Covestor’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6K Sell
75
-481
-87% -$50.2K ﹤0.01% 1801
2026
Q2 		$65K Sell
556
-85
-13% -$8.53K 0.04% 634
2026
Q1 		$59K Sell
641
-639
-50% -$60.1K 0.04% 602
2025
Q4 		$101K Buy
1,280
+1,239
+3,022% +$88.9K 0.05% 574
2025
Q3 		$3K Hold
41
– – ﹤0.01% 1888
2025
Q2 		$2K Sell
41
-9
-18% -$401 ﹤0.01% 1859
2025
Q1 		$2K Sell
50
-21
-30% -$990 ﹤0.01% 1861
2024
Q4 		$3K Buy
71
+56
+373% +$2.33K ﹤0.01% 1812
2024
Q3 		$1K Sell
15
-8
-35% -$319 ﹤0.01% 2035
2024
Q2 		$1K Buy
23
+20
+667% +$524 ﹤0.01% 2052
2024
Q1 		$0 Hold
3
– – ﹤0.01% 2539
2023
Q4 		$0 Sell
3
-1
-25% -$30 ﹤0.01% 2480
2023
Q3 		$0 Hold
4
– – ﹤0.01% 2461
2023
Q2 		$0 Buy
+4
New +$106 ﹤0.01% 2443
2022
Q4 		– Sell
-1
Closed – – 2380
2022
Q3 		$0 Buy
+1
New +$24 ﹤0.01% 2352

Other funds holding MIRM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Penn Capital Management
Penn Capital Management Philadelphia, Pennsylvania $1.37B AUM 42.56% 1-Year Est. Return

Covestor's MIRM Position: Q3 2026 in Review

Covestor reduced its Mirum Pharmaceuticals (MIRM) stake by 87% in Q3 2026, selling an estimated $50.2K and leaving 75 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1801.

Covestor first reported a position in MIRM in Q3 2022 and has held it in 15 quarters since. The position peaked at $101K in Q4 2025. 139 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • Covestor held 75 shares of Mirum Pharmaceuticals worth $6K as of Q3 2026.
  • Covestor sold 481 Mirum Pharmaceuticals shares in Q3 2026, an estimated $50.2K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #1801 holding.
  • Covestor first reported a position in Mirum Pharmaceuticals in Q3 2022 and has held it in 15 quarters since.
  • Covestor's Mirum Pharmaceuticals position peaked at $101K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.